Experts urge clinicians to focus on stroke prevention benefits when counseling patients about carotid revascularization.

Mavacamten (Camzyos) is now approved by the US Food and Drug Administration for use not only in adults, but also in pediatric patients with obstructive hypertrophic cardiomyopathy (HCM) who weigh at ...

ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of ...

Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.

A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.

The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...

The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...

Leaders call for removal of this outdated metric, which they say has no bearing over ongoing interventional cardiologist ...

Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.

Office-based CCTA may be a tool cardiologists practicing in rural areas can use to identify at-risk patients earlier.

The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

Lead author Amar Rai, MBBS (University of Pennsylvania, Philadelphia, and Imperial College London, England), said that as a clinician working with patients who have high bleeding risks in general, he ...